Published in Healthcare Finance, Tax and Law Weekly, October 18th, 2006
The proceeds from this financing will be used to further develop the company's Dynamic adjustable cardiovascular implant technologies and initial human clinical trials for its initial products.
MiCardia is developing a technology for the minimally invasive and noninvasive adjustable cardiovascular implants for the treatment of various stages of congestive heart...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.